CORDIS
EU research results

CORDIS

English EN

Role and Modulation of Jak and STAT signaling in Graft Rejection and Graft versus Host Disease

Objective

Our interest is to extend the understanding of Jak and STAT signaling in the immunologic processes conditioning the outcome of allogeneic hematopoietic stem cell transplant (allo-HSCT) and to develop new strategies to overcome graft rejection (GR) and graft versus host disease (GVHD).
Allo-HSCT is a potentially curative strategy for many patients. GR and GVHD hamper the success of allo-HSCT by conditioning treatment related mortality. The Janus family of kinase (Jaks) dictates T helper (Th) cells differentiation through the activation of different members of the STAT family.
We hypothesize that Jak and STAT signaling play an important role for mediating GR and GVHD and propose to: 1) evaluate the activation of Jaks and STATs after transplant in patients with or without GVHD; 2) analyze the kinetics of activation of Jaks and STATs in mouse models of GR and GVHD; 3) determine whether Jak3 has a non-dispensable role in alloreactive-driven, such as GR and GVHD, or homeostatic-driven T cell expansion; 4) explore the possible interaction between STAT6 and STAT1 to dictate Th differentiation; 5) modulate GR and GVHD through the pharmacological manipulation of Jak signaling.
We plan to achieve these objectives by an inter-disciplinary approach consisting of the analysis of in vitro experiments, in vivo data and clinical data. Jak and STAT signaling will be studied on lymphocytes form patients undergoing allo-HSCT. In parallel, in vivo mouse models will explore the role of different Jak-STAT molecules in the onset of GR and GVHD by PCR, phospho-flow cytometry and western blotting. We will utilize mice deficient for different Jak-STAT molecules to demonstrate the causal role of these proteins in GR and GVHD. These mouse models will be instrumental to test the efficacy of new drugs that can modulate Jak and STAT signaling, such as CP-690,550.
Funding of this proposal will foster the European reintegration of a scientist with extensive training in the United States.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI

Address

Via Venezian 1
20133 Milan

Italy

Activity type

Research Organisations

EU Contribution

€ 75 000

Administrative Contact

Antonio Cannarozzo (Dr.)

Project information

Grant agreement ID: 268113

Status

Closed project

  • Start date

    1 February 2011

  • End date

    31 January 2014

Funded under:

FP7-PEOPLE

  • Overall budget:

    € 75 000

  • EU contribution

    € 75 000

Coordinated by:

FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI

Italy